Hyundai Pharmaceutical Co (XKRX:004310) Net Income (Continuing Operations) : ₩4,721 Mil (TTM As of Feb. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Hyundai Pharmaceutical Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Hyundai Pharmaceutical Co's Net Income (Continuing Operations) for the three months ended in Feb. 2024 was ₩309 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Feb. 2024 was ₩4,721 Mil.

Hyundai Pharmaceutical Co Net Income (Continuing Operations) Historical Data

The historical data trend for Hyundai Pharmaceutical Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Pharmaceutical Co Net Income (Continuing Operations) Chart

Hyundai Pharmaceutical Co Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

1,212.85

2,187.06

-3,173.18

-164.58

6,121.76

Hyundai Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															1,671.74	3,094.70	1,748.32	-430.92	309.18

Hyundai Pharmaceutical Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,721 Mil.

Hyundai Pharmaceutical Co (XKRX:004310) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Hyundai Pharmaceutical Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Pharmaceutical Co (XKRX:004310) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hyundai Pharmaceutical Co Ltd (XKRX:004310) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

Bonegeunsa Street 135, Hyundai Pharm Building, Gangnam-gu, Seoul, KOR, 135-545

Website

http://www.hyundaipharm.co.kr

Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.

Hyundai Pharmaceutical Co (XKRX:004310) Headlines

No Headlines